Playside Studios Ltd (PLY)
Australian Securities Exchange · Australia · prices in AUD · close of 21 Oct 2026
Key indicators
| Last close | AUD 0.092 |
|---|---|
| 52-week range | 0.090 – 0.390 |
| Return, 1 month / 3 months | −16.4% / −12.4% |
| Return, 1 year / 3 years | −59.1% / −79.1% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 97.5% |
| Worst drawdown (1 year) | -74.3% |
| Average daily value traded | 0.03M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PlaySide Studios is an Australian video game developer based in Melbourne. The studio creates games for mobile devices, personal computers and consoles, working both on its own original titles and on projects for other game publishers. Its output spans several genres, from strategy and action games to casual mobile experiences, and its customers are players around the world who download or purchase its games through digital storefronts and app marketplaces.
On this site Playside Studios Ltd appears as a stock on the Australian Securities Exchange (Australia), code PLY, with prices in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Playside Studios Ltd (PLY) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.092 on 21 October 2026.
Its price-based Market X-Ray is 21 out of 100 (a weak price profile), ranking 1,619 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 59.1% and over the last three months it fell 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -52.1% | ||
| From 52-week high | -73.7% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.4% | ||
| 6-month return | -67.7% | ||
| 12-month return, skipping the last month | -51.1% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 97.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -74.3% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −16.4% |
| 3 months | −12.4% |
| 6 months | −67.7% |
| 1 year | −59.1% |
| 3 years | −79.1% |
| 5 years | −83.3% |
Signals
| 50-day / 200-day average | 0.112 / 0.192 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.006 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.